Peptonic Medical AB (publ) (the "Company") announces a change to the publication date of its interim report for the third quarter of 2026. The publication date has been changed from November 10, 2026, to November 26, 2026. The postponement is due to administrative reasons.
For further information, please contact:
Daniel Rudeklint, Interim CEO
Peptonic Medical AB
Email: daniel.rudeklint@peptonicmedical.se
Phone: +46 73-158 02 73
About Peptonic Medical AB
Peptonic Medical AB (publ) is a Swedish women's health company that develops and markets products within intimate self-care, health and well-being. The Company's strategy is based on developing a broad product portfolio under its own brands, combined with international expansion through strategic distribution and brand partnerships.
Peptonic Medical is listed on Spotlight Stock Market.